← Back

CTCBIO Inc

CTCBIO Inc. provides a range of pharmaceutical products in South Korea and internationally. Its offerings include animal and human pharmaceuticals, feed additives and ingredients, and functional food products. The company also supplies products across therapeutic areas such as cardiovascular, gastrointestinal, osteoporosis, antibiotics, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genitourinary, antihistamine, neuropsychiatry, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and hormones, along with the CTC COVID-19 IgM/IgG combo test, a rapid antibody test kit for COVID-19. In addition, it offers coating bases, plasticizers, pore formers, diluting agents, bonding agents, disintegrating agents, lubricants, solubilizers/biopharma, topicals, APIs, and food/health functional foods, as well as animal drugs, physiological activators, functional enhancers, and disinfectants. CTCBIO Inc. was founded in 1993 and is headquartered in Hwaseong-si, South Korea.

Price · split & dividend adjusted
News & notes moving 060590.KQ